GGrantIndex
← Search

PACTG P1047: PHASE II SAFETY AND IMMUNOGENICITY STUDY OF QUADRIVALENT

$40,755M01FY2007RRNIH

University Of Colorado Denver, Aurora CO

Investigators

Linked publications & trials

View original record on NIH RePORTER →